New evaluation of patients eligible for active surveillance protocols
January 12th, 2010 Posted in UncategorizedA recent study at CHU Henri Mondor, Créteil, France, has compared the pathological findings and prostate specific antigen outcome after radical prostatectomy in men eligible for active surveillance according to 3 biopsy inclusion criteria.
The team has added to the data correlating risk for progression in patients on active surveillance (AS) protocols with pathological outcomes and biochemical recurrence in radical prostatectomy series. Interestingly, while they show clearly that the two out of their three AS protocols that had less restrictive entry criteria have a higher risk for inclusion of men with stage pT3-4 cancers or Gleason 8 disease, they also showed that the 3-year rate of biochemical recurrence-free survival in their three very different AS protocol groups was exactly the same – at 94 percent.